Malcolm Farquharson
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
-
- CRISPR and Genetic Engineering 4
- Viral Infectious Diseases and Gene Expression in Insects 1
-
- Ovarian cancer diagnosis and treatment 4
- Co-authors
- Iain A. McNeish (5 shared papers)Suzanne Dowson (5 shared papers)Josephine Walton (4 shared papers)Karen Blyth (4 shared papers)Susan Mason (4 shared papers)David Stevenson (4 shared papers)Darren Ennis (3 shared papers)Elaine Leung (3 shared papers)
- Journals
- Scientific Reports (1 paper)Molecular Therapy — Oncolytics (1 paper)Clinical Cancer Research (1 paper)Cancer Research (1 paper)PMC (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Malcolm Farquharson
6 papers receiving 255 citations
Peers
Comparison fields: 5 of 42
- Reproductive Medicine 56
- Oncology 138
- Immunology 88
- Cancer Research 45
- Structural Biology 3
Countries citing papers authored by Malcolm Farquharson
This map shows the geographic impact of Malcolm Farquharson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Farquharson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Farquharson more than expected).
Fields of papers citing papers by Malcolm Farquharson
This network shows the impact of papers produced by Malcolm Farquharson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Farquharson. The network helps show where Malcolm Farquharson may publish in the future.
Co-authors
The 25 scholars most cited alongside Malcolm Farquharson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 150 | |
| 2 | 2017 | 66 | |
| 3 | 2020 | 35 | |
| 4 | CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity | 2017 | 2 |
| 5 | 2011 | 1 | |
| 6 | 2018 | 1 |
About Malcolm Farquharson
Malcolm Farquharson is a scholar working on Molecular Biology, Reproductive Medicine, Oncology, Surgery and Obstetrics and Gynecology, having authored 6 papers that have together received 255 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), CRISPR and Genetic Engineering (4 papers), CAR-T cell therapy research (1 paper), PARP inhibition in cancer therapy (1 paper), Cancer-related molecular mechanisms research (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Endometrial and Cervical Cancer Treatments (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Reproductive Medicine (56 citations), Oncology (138 citations), Immunology (88 citations), Cancer Research (45 citations) and Structural Biology (3 citations). Malcolm Farquharson has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Iain A. McNeish, Suzanne Dowson, Josephine Walton, Karen Blyth, Susan Mason, David Stevenson, Darren Ennis, Elaine Leung, Karen H. Vousden and Dimitris Athineos. Their work appears in journals such as Scientific Reports, Molecular Therapy — Oncolytics, Clinical Cancer Research, Cancer Research and PMC.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.